AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.46+1.10 (+0.32%) ▲|BA215.26-1.99 (-0.92%) ▼|BAC58.04+0.16 (+0.28%) ▲|BKNG183.39+1.93 (+1.06%) ▲|BLK952.72-11.99 (-1.24%) ▼|BMY58.45+0.93 (+1.62%) ▲|BNY144.11+0.55 (+0.38%) ▲|BRK-B495.95-2.71 (-0.54%) ▼|C142.79+1.03 (+0.73%) ▲|CAT1,033.24+35.77 (+3.59%) ▲|CL91.98-0.09 (-0.10%) ▼|CMCSA24.44+1.27 (+5.46%) ▲|COF202.35-1.65 (-0.81%) ▼|COP104.43-1.53 (-1.44%) ▼|COST944.98-7.56 (-0.79%) ▼|CRM158.45+0.08 (+0.05%) ▲|CSCO117.47+3.70 (+3.25%) ▲|CVS103.36-0.98 (-0.94%) ▼|CVX168.84-2.22 (-1.30%) ▼|DE624.07+10.83 (+1.77%) ▲|DHR193.19-3.00 (-1.53%) ▼|DIS98.65-0.14 (-0.14%) ▼|DUK128.03-0.37 (-0.29%) ▼|EMR142.90-0.59 (-0.41%) ▼|FDX324.51+5.98 (+1.88%) ▲|GD348.45+1.74 (+0.50%) ▲|GE373.26+4.26 (+1.15%) ▲|GEV1,099.27+54.10 (+5.18%) ▲|GILD126.10-1.78 (-1.39%) ▼|GM77.52-0.59 (-0.75%) ▼|GOOG350.91+16.22 (+4.84%) ▲|GOOGL353.32+15.93 (+4.72%) ▲|GS1,023.93+4.32 (+0.42%) ▲|HD349.92+1.06 (+0.30%) ▲|HON227.58-15.84 (-6.51%) ▼|IBM277.65+6.02 (+2.22%) ▲|INTC130.38+2.06 (+1.61%) ▲|INTU267.20-0.52 (-0.19%) ▼|ISRG405.76+1.49 (+0.37%) ▲|JNJ257.94+3.28 (+1.29%) ▲|JPM330.84+1.79 (+0.54%) ▲|KO82.58-0.05 (-0.06%) ▼|LIN510.87-8.75 (-1.68%) ▼|LLY1,228.14+20.02 (+1.66%) ▲|LMT503.10-4.30 (-0.85%) ▼|LOW220.15-2.34 (-1.05%) ▼|LRCX409.83+30.74 (+8.11%) ▲|MA510.87+11.85 (+2.37%) ▲|MCD267.18-2.58 (-0.96%) ▼|MDLZ60.11-0.69 (-1.13%) ▼|MDT80.74-0.25 (-0.30%) ▼|META564.45+14.20 (+2.58%) ▲|MMM162.43-1.59 (-0.97%) ▼|MO73.85+0.06 (+0.08%) ▲|MRK129.36+0.70 (+0.54%) ▲|MS212.57+0.54 (+0.25%) ▲|MSFT368.04-4.93 (-1.32%) ▼|MU1,128.19-4.14 (-0.37%) ▼|NEE88.53-0.03 (-0.03%) ▼|NFLX73.88+0.07 (+0.09%) ▲|NKE41.32+0.57 (+1.40%) ▲|NOW99.83+1.49 (+1.52%) ▲|NVDA194.62+2.09 (+1.09%) ▲|ORCL148.25-0.28 (-0.19%) ▼|PEP138.10-3.29 (-2.33%) ▼|PFE24.41+0.12 (+0.49%) ▲|PG147.91-1.11 (-0.74%) ▼|PLTR116.21+3.28 (+2.90%) ▲|PM182.48+1.71 (+0.95%) ▲|QCOM187.52-1.88 (-0.99%) ▼|RTX187.74-0.25 (-0.13%) ▼|SBUX104.11-0.49 (-0.47%) ▼|SCHW90.52-0.16 (-0.17%) ▼|SO96.72-0.44 (-0.45%) ▼|SPG227.69+0.80 (+0.35%) ▲|T21.79-0.93 (-4.09%) ▼|TMO505.11-7.92 (-1.54%) ▼|TMUS173.83-8.86 (-4.85%) ▼|TSLA411.51+31.80 (+8.37%) ▲|TXN284.54-0.89 (-0.31%) ▼|UBER75.20-1.00 (-1.31%) ▼|UNH418.44-9.45 (-2.21%) ▼|UNP272.41+4.06 (+1.51%) ▲|UPS107.98-0.16 (-0.15%) ▼|USB61.40+0.49 (+0.80%) ▲|V342.23+6.00 (+1.78%) ▲|VZ44.09-2.45 (-5.26%) ▼|WFC83.84-0.03 (-0.03%) ▼|WMT114.83-0.86 (-0.74%) ▼|XOM136.09-0.46 (-0.33%) ▼|AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.46+1.10 (+0.32%) ▲|BA215.26-1.99 (-0.92%) ▼|BAC58.04+0.16 (+0.28%) ▲|BKNG183.39+1.93 (+1.06%) ▲|BLK952.72-11.99 (-1.24%) ▼|BMY58.45+0.93 (+1.62%) ▲|BNY144.11+0.55 (+0.38%) ▲|BRK-B495.95-2.71 (-0.54%) ▼|C142.79+1.03 (+0.73%) ▲|CAT1,033.24+35.77 (+3.59%) ▲|CL91.98-0.09 (-0.10%) ▼|CMCSA24.44+1.27 (+5.46%) ▲|COF202.35-1.65 (-0.81%) ▼|COP104.43-1.53 (-1.44%) ▼|COST944.98-7.56 (-0.79%) ▼|CRM158.45+0.08 (+0.05%) ▲|CSCO117.47+3.70 (+3.25%) ▲|CVS103.36-0.98 (-0.94%) ▼|CVX168.84-2.22 (-1.30%) ▼|DE624.07+10.83 (+1.77%) ▲|DHR193.19-3.00 (-1.53%) ▼|DIS98.65-0.14 (-0.14%) ▼|DUK128.03-0.37 (-0.29%) ▼|EMR142.90-0.59 (-0.41%) ▼|FDX324.51+5.98 (+1.88%) ▲|GD348.45+1.74 (+0.50%) ▲|GE373.26+4.26 (+1.15%) ▲|GEV1,099.27+54.10 (+5.18%) ▲|GILD126.10-1.78 (-1.39%) ▼|GM77.52-0.59 (-0.75%) ▼|GOOG350.91+16.22 (+4.84%) ▲|GOOGL353.32+15.93 (+4.72%) ▲|GS1,023.93+4.32 (+0.42%) ▲|HD349.92+1.06 (+0.30%) ▲|HON227.58-15.84 (-6.51%) ▼|IBM277.65+6.02 (+2.22%) ▲|INTC130.38+2.06 (+1.61%) ▲|INTU267.20-0.52 (-0.19%) ▼|ISRG405.76+1.49 (+0.37%) ▲|JNJ257.94+3.28 (+1.29%) ▲|JPM330.84+1.79 (+0.54%) ▲|KO82.58-0.05 (-0.06%) ▼|LIN510.87-8.75 (-1.68%) ▼|LLY1,228.14+20.02 (+1.66%) ▲|LMT503.10-4.30 (-0.85%) ▼|LOW220.15-2.34 (-1.05%) ▼|LRCX409.83+30.74 (+8.11%) ▲|MA510.87+11.85 (+2.37%) ▲|MCD267.18-2.58 (-0.96%) ▼|MDLZ60.11-0.69 (-1.13%) ▼|MDT80.74-0.25 (-0.30%) ▼|META564.45+14.20 (+2.58%) ▲|MMM162.43-1.59 (-0.97%) ▼|MO73.85+0.06 (+0.08%) ▲|MRK129.36+0.70 (+0.54%) ▲|MS212.57+0.54 (+0.25%) ▲|MSFT368.04-4.93 (-1.32%) ▼|MU1,128.19-4.14 (-0.37%) ▼|NEE88.53-0.03 (-0.03%) ▼|NFLX73.88+0.07 (+0.09%) ▲|NKE41.32+0.57 (+1.40%) ▲|NOW99.83+1.49 (+1.52%) ▲|NVDA194.62+2.09 (+1.09%) ▲|ORCL148.25-0.28 (-0.19%) ▼|PEP138.10-3.29 (-2.33%) ▼|PFE24.41+0.12 (+0.49%) ▲|PG147.91-1.11 (-0.74%) ▼|PLTR116.21+3.28 (+2.90%) ▲|PM182.48+1.71 (+0.95%) ▲|QCOM187.52-1.88 (-0.99%) ▼|RTX187.74-0.25 (-0.13%) ▼|SBUX104.11-0.49 (-0.47%) ▼|SCHW90.52-0.16 (-0.17%) ▼|SO96.72-0.44 (-0.45%) ▼|SPG227.69+0.80 (+0.35%) ▲|T21.79-0.93 (-4.09%) ▼|TMO505.11-7.92 (-1.54%) ▼|TMUS173.83-8.86 (-4.85%) ▼|TSLA411.51+31.80 (+8.37%) ▲|TXN284.54-0.89 (-0.31%) ▼|UBER75.20-1.00 (-1.31%) ▼|UNH418.44-9.45 (-2.21%) ▼|UNP272.41+4.06 (+1.51%) ▲|UPS107.98-0.16 (-0.15%) ▼|USB61.40+0.49 (+0.80%) ▲|V342.23+6.00 (+1.78%) ▲|VZ44.09-2.45 (-5.26%) ▼|WFC83.84-0.03 (-0.03%) ▼|WMT114.83-0.86 (-0.74%) ▼|XOM136.09-0.46 (-0.33%) ▼|
30.5 C
New York
Monday, June 29, 2026

Tag: litigation

newssourceFORcompanyinformationcontent1releasesmarket

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. – UNCY

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE – ARGX

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  argenx SE (“argenx” or the “Company”) (NASDAQ: ARGX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. – DYN

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. – EWTX

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc. – KBR

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc.  (“KBR” or the “Company”) (NYSE: KBR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lockheed Martin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – LMT

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lockheed Martin Corporation (NYSE: LMT) between January 23, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), of the important September 26, 2025 lead plaintiff deadline.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of American Outdoor Brands, Inc. – AOUT

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  American Outdoor Brands, Inc. (“American Outdoor” or the “Company”) (NASDAQ: AOUT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Thumzup Media Corporation Announces Update to the Terms of its Proposed Public Offering

LOS ANGELES, Aug. 9, 2025 /PRNewswire/ -- Thumzup Media Corporation (Nasdaq: TZUP) ("Thumzup" or the "Company"), a digital asset accumulator and advertising industry disruptor, today...

Pomerantz Law Firm Announces the Filing of a Class Action Against CTO Realty Growth, Inc. and Certain Officers – CTO

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO) and certain officers.   The class action, filed in the United States District Court for the Middle District of Florida, and docketed under 25-cv-01516, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CTO securities between February 18, 2021 and June 24, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

BRBR NEWS: Did BellRing Brands, Inc. Mislead Investors? Contact BFA Law about its Investigation into the Company (NYSE:BRBR)

BellRing Brands, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.

Thumzup Media Corporation Announces Proposed Public Offering

LOS ANGELES, Aug. 8, 2025 /PRNewswire/ -- Thumzup Media Corporation (Nasdaq: TZUP) ("Thumzup" or the "Company"), a digital asset accumulator and advertising industry disruptor, today...

Star Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred Stock 

The dividend will cover the period through August 21, 2025 
The dividend will cover the period through August 21, 2025

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has entered into a securities purchase agreement with Janus Henderson Investors, a global asset management firm, to purchase 20,000,000 shares of common stock and warrants to purchase up to an aggregate of 20,000,000 shares of common stock at a purchase price of $1.00 per share (closing price on August 7, 2025) and accompanying warrant in a registered direct offering. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire two years following the date of issuance. The warrants are callable by the Company when the VWAP of the Company’s common stock exceeds $2.50 per share for at least five of a trailing 30 trading day period. 

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 10,200 shares of its common stock to fourteen newly-hired employees, with a grant date of August 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLitigation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers